BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12351679)

  • 1. Metapopulation dynamics and spatial heterogeneity in cancer.
    González-García I; Solé RV; Costa J
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13085-9. PubMed ID: 12351679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.
    Kim SJ; Im YH; Markowitz SD; Bang YJ
    Cytokine Growth Factor Rev; 2000; 11(1-2):159-68. PubMed ID: 10708963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
    Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
    Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas.
    Venkatasubbarao K; Ahmed MM; Swiderski C; Harp C; Lee EY; McGrath P; Mohiuddin M; Strodel W; Freeman JW
    Genes Chromosomes Cancer; 1998 Jun; 22(2):138-44. PubMed ID: 9598801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.
    Chowdhury S; Howell GM; Teggart CA; Chowdhury A; Person JJ; Bowers DM; Brattain MG
    J Biol Chem; 2011 Sep; 286(35):30937-30948. PubMed ID: 21757750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer.
    Saeterdal I; Bjørheim J; Lislerud K; Gjertsen MK; Bukholm IK; Olsen OC; Nesland JM; Eriksen JA; Møller M; Lindblom A; Gaudernack G
    Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13255-60. PubMed ID: 11687624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability.
    Pino MS; Kikuchi H; Zeng M; Herraiz MT; Sperduti I; Berger D; Park DY; Iafrate AJ; Zukerberg LR; Chung DC
    Gastroenterology; 2010 Apr; 138(4):1406-17. PubMed ID: 20026115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
    Wikström P; Bergh A; Damber JE
    Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.
    Lee J; Ballikaya S; Schönig K; Ball CR; Glimm H; Kopitz J; Gebert J
    PLoS One; 2013; 8(2):e57074. PubMed ID: 23468914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G
    Mol Biol Rep; 2012 Apr; 39(4):4301-9. PubMed ID: 21785915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
    Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
    Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
    Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG
    BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.
    Izumoto S; Arita N; Ohnishi T; Hiraga S; Taki T; Tomita N; Ohue M; Hayakawa T
    Cancer Lett; 1997 Jan; 112(2):251-6. PubMed ID: 9066736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms.
    Souza RF; Lei J; Yin J; Appel R; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Meltzer SJ
    Gastroenterology; 1997 Jan; 112(1):40-5. PubMed ID: 8978341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.